Jack Cuzick

Research interests

Publications

• Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00288-6

• Key steps for effective breast cancer prevention

  Nature reviews. Cancer · 2020 · 10.1038/s41568-020-0266-x

• Personalized early detection and prevention of breast cancer: ENVISION consensus statement

  Nature Reviews Clinical Oncology · 2020 · https://doi.org/10.1038/s41571-020-0388-9

• Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31821-4

• De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx308

• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5

• A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1405044

• Prevention and early detection of prostate cancer

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70211-6

• Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)60140-3

• Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.49.3122

• Comprehensive Control of Human Papillomavirus Infections and Related Diseases

  Vaccine · 2013 · https://doi.org/10.1016/j.vaccine.2013.10.003

• Comprehensive Control of Human Papillomavirus Infections and Related Diseases

  Vaccine · 2013 · https://doi.org/10.1016/j.vaccine.2013.07.026

• Comparison of PAM50 Risk of Recurrence Score With Onco type DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.46.1558

• Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

  The Lancet · 2013 · 10.1016/s0140-6736(13)62292-8

• Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

  The Lancet Oncology · 2011 · 10.1016/s1470-2045(10)70295-3

• Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.31.2835

• The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women

  International Journal of Obesity · 2010 · https://doi.org/10.1038/ijo.2010.171

• Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

  The Lancet · 2010 · 10.1016/s0140-6736(10)60551-x

• Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.24.4798

• Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

  The Lancet Oncology · 2010 · 10.1016/s1470-2045(10)70257-6

• Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

  The Lancet Oncology · 2010 · 10.1016/s1470-2045(09)70360-2

• Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.1274

• Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

  The Lancet Oncology · 2009 · 10.1016/s1470-2045(09)70035-x

• Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

  BMJ · 2008 · 10.1136/bmj.a1754

• Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.11.0726

• Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

  International Journal of Cancer · 2008 · https://doi.org/10.1002/ijc.24010

• Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

  Vaccine · 2008 · 10.1016/j.vaccine.2008.06.019

• Overview of the European and North American studies on HPV testing in primary cervical cancer screening

  International Journal of Cancer · 2006 · 10.1002/ijc.21955

• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

  The Lancet · 2005 · 10.1016/s0140-6736(04)17666-6

• A breast cancer prediction model incorporating familial and personal risk factors

  Statistics in Medicine · 2004 · 10.1002/sim.1668

• Overview of the main outcomes in breast-cancer prevention trials

  The Lancet · 2003 · 10.1016/s0140-6736(03)12342-2

• Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

  Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.3.447

• Long-Term Risk of Colorectal Cancer after Excision of Rectosigmoid Adenomas

  New England Journal of Medicine · 1992 · 10.1056/nejm199203053261002

• Leukemia Following Hodgkin's Disease

  New England Journal of Medicine · 1990 · https://doi.org/10.1056/nejm199001043220102

• A wilcoxon‐type test for trend

  Statistics in Medicine · 1985 · 10.1002/sim.4780040112

Current projects

No projects listed.